{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:27:59Z","timestamp":1785572879003,"version":"3.56.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RBSI14EDX9"],"award-info":[{"award-number":["RBSI14EDX9"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0208709","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T18:53:07Z","timestamp":1544554387000},"page":"e0208709","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach"],"prefix":"10.1371","volume":"13","author":[{"given":"Silvia","family":"Da Ros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Aresu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ferraresso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Zorzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-8983","authenticated-orcid":true,"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Dacasto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-3800","authenticated-orcid":true,"given":"Mery","family":"Giantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The Epigenomics of Cancer","volume":"128","author":"PA Jones","year":"2007","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2165\/11596690-000000000-00000","article-title":"Epigenetic-Based Therapies in Cancer\u2014Progress to Date","volume":"71","author":"SH Song","year":"2011","journal-title":"Drugs"},{"key":"ref3","first-page":"121","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"CB Yoo","year":"2006","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tig.2013.11.004","article-title":"Mining cancer methylomes: prospects and challenges","volume":"30","author":"C Stirzaker","year":"2014","journal-title":"Trends in Genetics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in Cancer","volume":"358","author":"M Esteller","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylase and cancer: causes and therapies","volume":"1","author":"PA Marks","year":"2001","journal-title":"Nature Reviews Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"X Nan","year":"1998","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/5047","article-title":"Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer","volume":"21","author":"EE Cameron","year":"1999","journal-title":"Nature Genetics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-08-2788","article-title":"Epigenetic Modifiers: Basic Understanding and Clinical Development","volume":"15","author":"RL Piekarz","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.biochi.2012.07.025","article-title":"DNA methylation inhibitors in cancer: recent and future approaches","volume":"94","author":"C Gros","year":"2012","journal-title":"Biochimie"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e95596","DOI":"10.1371\/journal.pone.0095596","article-title":"Separate and combined effects of DNMT and HDAC inhibitors in treating human multi-drug resistant osteosarcoma HosDXR150 cell line","volume":"9","author":"E Capobianco","year":"2014","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/genes6030812","article-title":"Epigenetic Heterogeneity of B-Cell Lymphoma: DNA Methylation, Gene Expression and Chromatin States","volume":"6","author":"L Hopp","year":"2015","journal-title":"Genes"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tvjl.2010.04.027","article-title":"The staging and treatment of multicentric high-grade lymphoma in dogs: A review of recent developments and future prospects","volume":"188","author":"L Marconato","year":"2011","journal-title":"The Veterinary Journal"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vetimm.2013.05.014","article-title":"Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: Might c-kit represent a therapeutic target?","volume":"154","author":"M Giantin","year":"2013","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e72591","DOI":"10.1371\/journal.pone.0072591","article-title":"Comparative Gene Expression Profiling Identifies Common Molecular Signatures of NF-\u0138B Activation in Canine and Human Diffuse Large B Cell Lymphoma (DLBCL)","volume":"8","author":"MA Mudaliar","year":"2013","journal-title":"PloS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1158\/0008-5472.CAN-12-3546","article-title":"Gene profiling of canine B-cell lymphoma reveals germinal center and post-germinal center subtypes with different survival times, modeling human DLBCL","volume":"73","author":"KL Richards","year":"2013","journal-title":"Cancer Research"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tvjl.2014.03.006","article-title":"Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma","volume":"200","author":"L Aresu","year":"2014","journal-title":"The Veterinary Journal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fvets.2016.00077","article-title":"Canine Lymphoma, More Than a Morphological Diagnosis: what we have learned about Diffuse Large B-Cell Lymphoma","volume":"3","author":"L Aresu","year":"2016","journal-title":"Frontiers in Veterinary Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/01652176.2016.1152633","article-title":"Canine lymphoma: a review","volume":"36","author":"M Zandvliet","year":"2016","journal-title":"Veterinary Quarterly"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e92707","DOI":"10.1371\/journal.pone.0092707","article-title":"Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma","volume":"9","author":"S Ferraresso","year":"2014","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rvsc.2014.04.008","article-title":"Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells","volume":"97","author":"A Fujiwara-Igarashi","year":"2014","journal-title":"Research in Veterinary Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.vetimm.2014.08.011","article-title":"Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors","volume":"161","author":"M Sato","year":"2014","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tvjl.2013.10.022","article-title":"Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients","volume":"199","author":"H Tomiyasu","year":"2014","journal-title":"The Veterinary Journal"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.juro.2011.09.010","article-title":"Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development","volume":"187","author":"NM Hahn","year":"2012","journal-title":"The Journal of Urology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/vco.12159","article-title":"Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs","volume":"15","author":"CM Fulkerson","year":"2015","journal-title":"Veterinary and Comparative Oncology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12917-014-0290-8","article-title":"6-Thioguanine and zebularine down-regulate DNMT1 and globally demethylate canine malignant lymphoid cells","volume":"10","author":"BK Flesner","year":"2014","journal-title":"BMC Veterinary Research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00280-010-1287-z","article-title":"The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin","volume":"67","author":"LA Wittenburg","year":"2011","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.leukres.2010.01.021","article-title":"Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma","volume":"34","author":"BC R\u00fctgen","year":"2010","journal-title":"Leukemia Research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"11591","DOI":"10.1038\/s41598-017-11724-w","article-title":"DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma","volume":"7","author":"S Ferraresso","year":"2017","journal-title":"Scientific Reports"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands","volume":"93","author":"JG Herman","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2144\/000114087","article-title":"Optimizing methodologies for PCR-based DNA methylation analysis","volume":"55","author":"HG Hern\u00e1ndez","year":"2013","journal-title":"BioTechniques"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1093\/nar\/gnh122","article-title":"A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus","volume":"32","author":"M Zeschnigk","year":"2004","journal-title":"Nucleic Acids Research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.rvsc.2012.07.035","article-title":"Expression of the aryl hydrocarbon receptor pathway and cyclooxygenase-2 in dog tumors","volume":"94","author":"M Giantin","year":"2013","journal-title":"Research in Veterinary Science"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tvjl.2016.03.024","article-title":"Transcriptomic analysis identified up-regulation of a solute carrier transporter and UDP glucuronosyltransferases in dogs with aggressive cutaneous mast cell tumours","volume":"212","author":"M Giantin","year":"2016","journal-title":"The Veterinary Journal"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-\u0394\u0394CT Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0300-483X(89)90120-0","article-title":"Preclinical evaluation of hematopoietic toxicity of antileukemic agent, 5-aza-2'-deoxycytidine","volume":"57","author":"RL Momparler","year":"1989","journal-title":"Toxicology"},{"key":"ref37","first-page":"592","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogs","volume":"43","author":"GG Chabot","year":"1983","journal-title":"Cancer Research"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00180191","article-title":"Pharmacokinetics of 5,6-dihydro-5-azacytidine (NSC-264880) in the foxhound","volume":"1","author":"L Malspeis","year":"1983","journal-title":"Investigational New Drugs"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/187231207780363642","article-title":"Disposition of vorinostat, a novel histone deacetylase inhibitor and anticancer agent, in preclinical species","volume":"1","author":"P Sandhu","year":"2007","journal-title":"Drug Metabolism Letters"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1091581809352111","article-title":"Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat","volume":"29","author":"JS Kerr","year":"2010","journal-title":"International Journal of Toxicology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1158\/1078-0432.CCR-10-1238","article-title":"Phase I Pharmacokinetic and Pharmacodynamic Evaluation of Combined Valproic Acid\/Doxorubicin Treatment in Dogs with Spontaneous Cancer","volume":"16","author":"LA Wittenburg","year":"2010","journal-title":"Clinical Cancer Research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.ejca.2005.08.014","article-title":"Homeobox gene expression in cancer: insights from developmental regulation and deregulation","volume":"41","author":"S Samuel","year":"2015","journal-title":"European Journal of Cancer"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/gcc.20687","article-title":"DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma","volume":"48","author":"LB Bennett","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2826","article-title":"The Hox genes and their roles in oncogenesis","volume":"10","author":"N Shah","year":"2010","journal-title":"Nature Reviews Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2119\/molmed.2011.00172","article-title":"Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis","volume":"18","author":"L Wang","year":"2012","journal-title":"Molecular Medicine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13148-011-0043-5","article-title":"Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia","volume":"2","author":"C Oing","year":"2011","journal-title":"Clinical Epigenetics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.onc.1210669","article-title":"The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation","volume":"27","author":"J Veeck","year":"2008","journal-title":"Oncogene"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2353\/ajpath.2007.061111","article-title":"Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells","volume":"170","author":"X Zhu","year":"2007","journal-title":"The American Journal of Pathology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bbrc.2007.04.051","article-title":"Aberrant hypermethylation of the FGFR2 gene in human gastric cancer cell lines","volume":"357","author":"S Park","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref50","first-page":"re1","article-title":"Nonredundant Functions for Ras GTPase-Activating Proteins in Tissue Homeostasis","volume":"6","author":"PD King","year":"2013","journal-title":"Sci Signal"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/eji.201444977","article-title":"RASAL3, a novel hematopoietic RasGAP protein, regulates the number and functions of NKT cells","volume":"45","author":"S Saito","year":"2015","journal-title":"European Journal of Immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjh.13566","article-title":"The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma","volume":"171","author":"E Marchi","year":"2015","journal-title":"British Journal of Haematology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"AC West","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4161\/epi.32089","article-title":"Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype","volume":"9","author":"V Kloten","year":"2014","journal-title":"Epigenetics"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"12353","DOI":"10.1073\/pnas.0700153104","article-title":"Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers","volume":"104","author":"H Jin","year":"2007","journal-title":"PNAS"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1002\/cncr.26073","article-title":"Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2\/M arrest, and autophagy","volume":"117","author":"MY Chen","year":"2011","journal-title":"Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1182\/blood-2011-02-336891","article-title":"HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL","volume":"118","author":"M Kalac","year":"2011","journal-title":"Blood"},{"key":"ref58","first-page":"371087","article-title":"Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I\/II Report","volume":"2014","author":"H Fan","year":"2014","journal-title":"Journal of Immunology Research"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13148-016-0245-y","article-title":"Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients","volume":"8","author":"B Pera","year":"2016","journal-title":"Clinical Epigenetics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0208709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:35:54Z","timestamp":1589009754000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0208709"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0208709","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]}}}